IBO vs SHW · rev $10.0K vs P/E 29, rev $12.46B
Impact BioMedical, Inc. (IBO) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported IBO revenue for 2026-06-30 was $10.0K. Net income was -$3.0M. Revenue was up 42.9% from 2026-03-31 to 2026-06-30. IBO currently screens at market cap $7.6M.
Latest reported SHW revenue for 2026-06-30 was $12.46B. Net income was $1.38B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
IBO currently screens at market cap $7.6M. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the IBO and SHW stock pages for the full models.
Not investment advice.